Literature DB >> 27446416

Dual role of macrophages in the response of C26 colon carcinoma cells to 5-fluorouracil administration.

Laura Patras1, Alina Sesarman1, Emilia Licarete1, Lavinia Luca1, Marius Costel Alupei1, Elena Rakosy-Tican2, Manuela Banciu1.   

Abstract

Previous studies have demonstrated that tumor-associated macrophages (TAMs) are pivotal players in tumor progression via modulation of tumor angiogenesis, inflammation, metastasis and oxidative stress, as well as of the response of cancer cells to cytotoxic drugs. Nevertheless, the role of TAMs in the prognosis of colorectal cancer remains controversial. Therefore, the present study aimed to investigate how TAMs mediate the response of C26 colon carcinoma cells to the cytotoxic drug 5-fluorouracil (5-FU), upon TAM co-cultivation with these cancer cells in vitro. In this respect, 5-FU cytotoxicity was assessed in C26 cells in standard culture and in a co-culture with peritoneal macrophages, the production of NF-κB was determined by western blot analysis, and the production of angiogenic/inflammatory proteins in each experimental model was evaluated by protein array analysis. To gain further evidence of the effect of TAMs on oxidative stress, malondialdehyde was measured through high-performance liquid chromatography, and the total nonenzymatic antioxidant levels and the production of nitrites were measured through colorimetric assays. The results demonstrated that TAMs exerted a dual role in the response of C26 cells to 5-FU administration in the co-culture model. Thus, on one side, TAMs sensitized C26 cells to 5-FU administration through inhibition of the production of inflammatory and angiogenic proteins in these cancer cells; however, they also protected cancer cells against 5-FU-induced oxidative stress. Collectively, the present findings suggest that the combined administration of 5-FU with pharmacological agents that prevent TAMs to maintain the physiological range of tumor cell oxidative stress may highly improve the therapeutic potential of this drug.

Entities:  

Keywords:  5-fluorouracil; angiogenesis; co-culture; colon carcinoma cells; inflammation; tumor-associated macrophages

Year:  2016        PMID: 27446416      PMCID: PMC4950715          DOI: 10.3892/ol.2016.4708

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  45 in total

Review 1.  Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors.

Authors:  M Crowther; N J Brown; E T Bishop; C E Lewis
Journal:  J Leukoc Biol       Date:  2001-10       Impact factor: 4.962

2.  5-Fluorouracil suppression of NF-KappaB is mediated by the inhibition of IKappab kinase activity in human salivary gland cancer cells.

Authors:  M Azuma; T Yamashita; K Aota; T Tamatani; M Sato
Journal:  Biochem Biophys Res Commun       Date:  2001-03-23       Impact factor: 3.575

Review 3.  A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress.

Authors:  Daniele Del Rio; Amanda J Stewart; Nicoletta Pellegrini
Journal:  Nutr Metab Cardiovasc Dis       Date:  2005-08       Impact factor: 4.222

4.  Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.

Authors:  Oriol Casanovas; Daniel J Hicklin; Gabriele Bergers; Douglas Hanahan
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

5.  Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.

Authors:  Kei Sakamoto; Shin Maeda; Yohko Hikiba; Hayato Nakagawa; Yoku Hayakawa; Wataru Shibata; Ayako Yanai; Keiji Ogura; Masao Omata
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

Review 6.  Redox control of inflammation in macrophages.

Authors:  Bernhard Brüne; Nathalie Dehne; Nina Grossmann; Michaela Jung; Dmitry Namgaladze; Tobias Schmid; Andreas von Knethen; Andreas Weigert
Journal:  Antioxid Redox Signal       Date:  2013-03-06       Impact factor: 8.401

7.  Targeting colon cancer cell NF-κB promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis.

Authors:  A E Ryan; A Colleran; A O'Gorman; L O'Flynn; J Pindjacova; P Lohan; G O'Malley; M Nosov; C Mureau; L J Egan
Journal:  Oncogene       Date:  2014-04-07       Impact factor: 9.867

8.  5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress.

Authors:  Monica Lamberti; Stefania Porto; Monica Marra; Silvia Zappavigna; Anna Grimaldi; Daniela Feola; Delia Pesce; Silvio Naviglio; Annamaria Spina; Nicola Sannolo; Michele Caraglia
Journal:  J Exp Clin Cancer Res       Date:  2012-07-19

9.  Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison.

Authors:  Tania Fiaschi; Paola Chiarugi
Journal:  Int J Cell Biol       Date:  2012-05-13

10.  Macrophage-tumor cell interactions regulate the function of nitric oxide.

Authors:  Michal A Rahat; Bernhard Hemmerlein
Journal:  Front Physiol       Date:  2013-06-18       Impact factor: 4.566

View more
  10 in total

1.  The novel gene HA117 promotes in vitro and in vivo drug resistance in mouse colon tumor cells.

Authors:  Y X Guo; Y H Xu; G H Zheng; X Q Jin
Journal:  Cancer Gene Ther       Date:  2017-07-21       Impact factor: 5.987

2.  Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo.

Authors:  Laura Patras; Bianca Sylvester; Lavinia Luput; Alina Sesarman; Emilia Licarete; Alina Porfire; Dana Muntean; Denise Minerva Drotar; Alexandra Doina Rusu; Andras-Laszlo Nagy; Cornel Catoi; Ioan Tomuta; Laurian Vlase; Manuela Banciu; Marcela Achim
Journal:  Cancer Biol Ther       Date:  2017-07-11       Impact factor: 4.742

3.  Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis.

Authors:  Giorgiana Negrea; Valentin-Florian Rauca; Marta Szilvia Meszaros; Laura Patras; Lavinia Luput; Emilia Licarete; Vlad-Alexandru Toma; Alina Porfire; Dana Muntean; Alina Sesarman; Manuela Banciu
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

4.  Macrophages induce "budding" in aggressive human colon cancer subtypes by protease-mediated disruption of tight junctions.

Authors:  Kari Trumpi; Nicola Frenkel; Timo Peters; Nicoline M Korthagen; Jennifer M J Jongen; Daniëlle Raats; Helma van Grevenstein; Yara Backes; Leon M Moons; Miangela M Lacle; Jan Koster; Danny Zwijnenburg; Inne H M Borel Rinkes; Onno Kranenburg
Journal:  Oncotarget       Date:  2018-04-13

5.  Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells.

Authors:  Valentin-Florian Rauca; Emilia Licarete; Lavinia Luput; Alina Sesarman; Laura Patras; Paul Bulzu; Elena Rakosy-Tican; Manuela Banciu
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

6.  Normoxic Tumour Extracellular Vesicles Modulate the Response of Hypoxic Cancer and Stromal Cells to Doxorubicin In Vitro.

Authors:  Laura Patras; Marcel H A M Fens; Pieter Vader; Arjan Barendrecht; Alina Sesarman; Manuela Banciu; Raymond Schiffelers
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923

7.  In Vivo Double Targeting of C26 Colon Carcinoma Cells and Microenvironmental Protumor Processes Using Liposomal Simvastatin.

Authors:  Lavinia Luput; Emilia Licarete; Denise Minerva Drotar; Andras-Laszlo Nagy; Alina Sesarman; Laura Patras; Valentin Florian Rauca; Alina Porfire; Dana Muntean; Marcela Achim; Ioan Tomuta; Laurian Vlase; Cornel Catoi; Nicolae Dragos; Manuela Banciu
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

8.  Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach.

Authors:  Lucia Ruxandra Tefas; Bianca Sylvester; Ioan Tomuta; Alina Sesarman; Emilia Licarete; Manuela Banciu; Alina Porfire
Journal:  Drug Des Devel Ther       Date:  2017-05-25       Impact factor: 4.162

9.  A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy.

Authors:  Elena De Mattia; Eva Dreussi; Marcella Montico; Sara Gagno; Chiara Zanusso; Luca Quartuccio; Salvatore De Vita; Michela Guardascione; Angela Buonadonna; Mario D'Andrea; Nicoletta Pella; Adolfo Favaretto; Enrico Mini; Stefania Nobili; Loredana Romanato; Erika Cecchin; Giuseppe Toffoli
Journal:  Front Pharmacol       Date:  2018-10-04       Impact factor: 5.810

10.  HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial-Mesenchymal Transition.

Authors:  Huachen Song; Xiaonan Tang; Xiang Li; Yufei Wang; Anjun Deng; Wenjie Wang; Haijing Zhang; Hailin Qin; LianQiu Wu
Journal:  Drug Des Devel Ther       Date:  2020-10-15       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.